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Within recent years needle biopsy of the liver has become an excellent
research as well as diagnostic tool, and the observations made available by
this technique have both theoretical and practical significance. With its
aid, base-line observations of liver morphology may be made and periodic
sampling thereafter may reflect the changes occurring in this organ as a
result of drug therapy.
With the use of this method preliminary observations of liver morphology
have been made before, during, and after treatment with aureomycin, terra-
mycin, Chloromycetin, streptomycin, para-amino-salicylic acid, and tibione.
Associated with aureomycin therapy fatty metamorphosis of the liver has
been observed.
Aureomycin. Four cases treated with aureomycin were studied.
Case $1. M. A., a 37-year-old white male was admitted to the hospital in February
1950 with recurrent acute brucellosis proved by six blood cultures, a liver, urine, and
bone marrow culture that were all positive for Brucella abortus. A liver biopsy on
2/10/50 showed numerous epithelioid granulomata in both portal triads and paren-
chymal areas. There was an occasional large fatty vacuole (Fig. 1). Aureomycin was
started on 2/16/50 and continued for fourteen days, for a total of 43 grams. Liver
biopsy on March 3, the day after completion of treatment, showed that epithelioid
granulomata were still present. There were numerous small vacuoles of fatty meta-
morphosis, most of the vacuoles approximating the size of the liver cell nuclei (Fig. 2).
Liver function studies on 2/16/50 revealed a bromsulphthalein retention of 11% and
a cephalin flocculation of ++. On 2/21/50, the bromsulphthalein was 6%o, the
cephalin flocculation ++, and the thymol turbidity ++. On 3/2/50 the bromsulph-
thalein was 0%s, the cephalin flocculation and thymol turbidity were negative. The
patient's temperature fell to normal on the fifth day of therapy and remained so
thereafter. During his stay in the hospital his weight remained constant at 205 pounds
although some anorexia and nausea accompanied the aureomycin therapy. A third liver
biopsy was done on April 15, 1950, 44 days after the cessation of aureomycin therapy,
and revealed an occasional small intrasinusoidal collection of reticulum cells. The
hepatic parenchymal cells contained only an occasional large fatty vacuole (Fig. 3).
* From the Veterans Administration Hospital, Newington, Connecticut and the
Departments of Pathology and Medicine, Yale University School of Medicine. Reviewed
in the Veterans Administration and published with the approval of the Chief Medical
Director. The statements and conclusions published by the authors are a result of
their own study and do not necessarily reflect the opinion or policy of the Veterans
Administration.
Received for publication November 20, 1950.YALE JOURNAL OF BIOLOGY AND MEDICINE
Case $2. S. R., a 52-year-old white male, was admitted to the hospital on February
1, 1950 with a febrile illness associated with a 25-pound weight loss and epithelioid
granulomata of the lymph nodes and bone marrow. Liver biopsy done on 2/18/50,
following a maximum weight loss, showed large granulomata present mid-zonally and
sharply circumscribed by envelopes of fibrous tissue. There was no fat in the paren-
chymal cells (Fig. 4). The differential diagnosis included sarcoidosis and brucellosis.
Because of the latter, although no positive cultures were obtained, aureomycin, 4.0
grams daily, was administered from March 8 through March 28, the patient receiving
a total of 84 grams. A repeat liver biopsy on April 2 revealed a moderate degree of
small cell vacuolization of the parenchymal cells, particularly in the central areas of
the lobules. The vacuoles tended to be about the size of parenchymal cell nuclei or
smaller (Fig. 5). No granulomata were present in the sections. Following cessation
of all chemotherapy the patient's temperature returned to normal, he became asymp-
tomatic, and was discharged on 6/16/50. He received no parenteral glucose and his
nutrition was maintained well by mouth.
Case $3. R. L. T., a 25-year-old white male, entered the hospital on September 14,
1950 with a history of headache of twelve days' duration and drenching night sweats
and fever of eight days' duration. He was a milk truck driver, and for one month
prior to admission had drunk raw milk for a period of ten days. Sternal and iliac bone
marrow cultures were positive for Brucella suis. A liver biopsy on 9/18/50 revealed
numerous epithelioid granulomata in both portal triads and parenchymal areas (Fig.
6). The parenchymal cells were devoid of fat. Aureomycin was started on 9/23/50 and
continued for fourteen days for a total of 94 grams. Liver biopsy on October 5, on
the thirteenth day of therapy, showed that epithelioid granulomata were still present.
There were numerous small vacuoles of fatty metamorphosis, most of the vacuoles
approximating the size of the liver cell nuclei (Fig. 7). Cephalin flocculation on
9/18/50 was 3+ and on 9/29/50 was 2+. Prior to therapy there was an occasional
spiking of temperature to 100°F. After aureomycin therapy was instituted, temperature
remained normal. During the period of aureomycin therapy he ate well and gained
10 pounds. A third liver biopsy done on 10/11/50, five days after cessation of aureo-
mycin therapy, revealed fatty metamorphosis still present, but not as extensive as in
the preceding biopsy. Sudan III stain of a frozen section confirmed the interpretation
of the vacuolization as lipoid droplets (Fig. 8).
Case #4. D. L. G., a 29-year-old white male, entered the hospital on June 12, 1950
with a history of fever, malaise, and jaundice of four days' duration. A diagnostic
liver biopsy on 6/19/50 revealed acute cholangitis. There was no fatty vacuolization
of the parenchymal cells. The patient continued to run a septic fever after admission
and on 6/21/50, aureomycin, 4.0 grams daily, was administered empirically for fourteen
days for a total of 56 grams. His temperature failed to respond to this therapy, but
gradually fell to normal after cessation of the antibiotic. A second liver biopsy was
performed on 7/21/50 and showed subacute cholangitis, early biliary cirrhosis, and
bile stasis. There was no fatty metamorphosis of the parenchymal cells. Because of a
recrudescence of his jaundice under observation, he was explored surgically on July
27, 1950 and chronic pancreatitis was found with enlarged lymph nodes in the region
of the common bile duct. During his hospitalization his weight fell from 121 pounds
to 109 pounds, and then rose to 113 pounds. His appetite was poor until the cessation
of aureomycin therapy, but his nutrition was maintained by a high protein diet.
Comment. a. Four patients were treated with aureomycin. In three a fine
fatty vacuolization was found immediately after 13 to 20 days of therapy.
In Case #4 the post-treatment biopsy failed to reveal fatty metamorphosis
but the biopsy was not done until sixteen days after treatment ceased. It is
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FIG. 1. M.A.: First biopsy. Small epithelioid granuloma is present; hepatic cells
are devoid of fat.
FIG. 2. M.A.: Second biopsy. Marked small vacuole fatty metamorphosis is present.
FIG. 3. M.A.: Third biopsy. Occasional large fat vacuole is present.
FIG. 4. S.R.: First biopsy. Small intrasinusoidal collection of reticulo-endothelial cells
is present; hepatic cells are devoid of fat.
:#
O'...5 6
a1y^8~~~ >.8 %14
FIG. 5. S.R.: Second biopsy. Moderate small vacuole fatty metamorphosis is present. FIG. 6. R.L.T.: First biopsy showing hepatic granulomata and no fat in the
parenchymal cells.
FIG. 7. R.L.T.: Second biopsy. Diffuse fatty metamorphosis. FIG. 8. R.L.T.: Third biopsy. Less marked fatty metamorphosis with Sudan IV
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possible that had the biopsy been done immediately following treatment,
the fatty change might have been demonstrable.
b. In one of the three cases (Case #1) with fatty metamorphosis of the
liver, a 44-day post-treatment liver biopsy revealed an occasional large fatty
vacuole, which was also present in the pretreatment biopsy.
c. These findings suggest that aureomycin was responsible for fatty
change in the liver. It is unlikely that the disease per se produced the fatty
change observed in Case #1, a chronic relapsing disease, or in Case #2, a
chronic disease, or in Case #3, an acute disease. Pretreatment biopsies in
each case showed absence of fatty change. Furthermore, the biopsy in Case
#2 was done at a time when weight loss was at a peak. The fatty change in
Cases #2 and #3 occurred only after aureomycin therapy, at a time when
the patients were improving clinically and were afebrile. Furthermore, it is
unlikely that a sampling error occurred in these adequate biopsies, because
it is our experience that when fatty change occurs in the liver it is of
remarkably uniform lobular distribution. Waldstein and Szanto8 have also
recently demonstrated that with respect to fatty metamorphosis and injury
of the epithelial liver cells, multiple needle biopsy specimens are almost
always uniform throughout the liver.
d. In Case #2 the patient developed a mild transient cheilosis at the
angles of the mouth for one week immediately following the cessation of
aureomycin therapy. This is similar to the riboflavin deficiency described
by Harris.' The mechanism involved is either an interference with the
absorption or utilization of riboflavin because of the induced change in the
intestinal flora, or a defect in utilization caused by aureomycin's interfering
with the enzyme systems. It is possible that similar mechanisms may cause
a deficiency of lipotropes in association with aureomycin therapy, resulting
in fatty metamorphosis of the liver. There was no clinical evidence of
vitamin deficiency in Cases #1 and #3.
Terramycin. In the following case, the effects of terramycin therapy were
noted.
Case $5. T. M. W., a 32-year-old white male with typhoid fever was given 28.5
grams of terramycin from August 26 to September 4, 1950. Liver biopsy on the sixth
day of terramycin therapy, after 17 grams, revealed absence of fatty metamorphosis.
Klatskin' has found fatty metamorphosis, similar to that seen following
aureo,mycin therapy, in one case two days after cessation of terramycin
therapy, in which 72 grams were given over a 16-day period. Control liver
biopsy four days prior to terramycin therapy revealed no fat. In a second
case, marked fatty metamorphosis of the liver was seen following the
administration of 31 grams of terramycin over a 9-day period. The control
liver biopsy one day prior to the institution of therapy was normal. This is
in contrast to Case #5, in which no fatty metamorphosis was found in the
liver at a time when only 17 grams of terramycin over a period of six days
had been administered.
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Tibione. In the following three cases the effects of tibione therapy alone
were evaluated. This study was undertaken during the course of an
investigation of the toxicity of tibione.
Case #6. R. D., a 57-year-old white male with old pulmonary tuberculosis was
admitted on July 14, 1949 for decortication of the right lung. Following his decortica-
tion, which was done without benefit of antibiotic therapy, he was placed on a 120-day
course of tibione, receiving 300 mg. a day. The liver biopsy on December 30, 1949,
before tibione was started, verified the clinical diagnosis of cirrhosis of the liver. The
parenchymal cells contained only the very smallest amount of lipoid vacuolization as
shown by the presence of a few tiny vacuoles in the periportal areas. The second liver
biopsy was done on May 2, 1950. The histologic appearance was identical with that
of the previous biopsy with the exception that the trace of fatty vacuolization had
disappeared.
Case #7. H. E., a 64-year-old white male who died as a result of widespread
carcinoma of renal origin, had a total of 35 days of treatment with tibione, 200 mg.
a day. The liver biopsy on December 12, 1949, done prior to treatment, revealed normal
hepatic tissue. At autopsy on February 16, 1950, the liver revealed marked invasion
by metastatic renal carcinoma. The uninvolved parenchyma was devoid of fatty
vacuolization or other changes.
Case i8. G. U., a 52-year-old white male, was admitted in delirium on November
17, 1949 with alcoholic cirrhosis. This patient received 90 days of tibione therapy in
amounts of 200 mg. a day. The first liver biopsy on December 28, 1949, before receiv-
ing tibione, revealed Laennec's cirrhosis. No fatty vacuolization was present. The
second and third liver biopsies on March 3, 1950 and on April 24, 1950, revealed no
change in the cirrhosis and no fatty metamorphosis. Groups of regenerating liver cells
were present in the third biopsy.
Comnment. In these three cases treated with tibione alone no evidence of
morphologic change was seen in the liver parenchyma.
Tibione, streptomycin, and para-amino-salicylic acid. The following three
cases with active tuberculosis were given tibione with various combinations
of streptomycin and para-amino-salicylic acid.
Case #9. R. E. B., a 30-year-old white male with bilateral far advanced upper lobe
tuberculosis was given tibione for a total of 142 days, 200 mg. a day, and streptomycin,
1 gram a day. The first liver biopsy obtained on January 13, 1950, before tibione was
started, revealed entirely normal hepatic tissue without any fatty metamorphosis. The
second biopsy obtained on June 15, 1950 also revealed hepatic tissue that was entirely
normal without any fatty metamorphosis.
Case #10. G. J. M., a 36-year-old white male with tuberculous synovitis was given
tibione for a total of 131 days, 200 mg. a day, and streptomycin, 1 gram every three
days. The first liver biopsy done prior to starting tibione therapy on February 9,
1950, revealed a normal lobular architecture. The parenchymal cells were normal and
ilevoid of fat. The second liver biopsy on June 23, 1950, performed nine days after the
cessation of tibione therapy, revealed the histologic characteristics of infectious
hepatitis. On April 25, 1950 this patient complained of anorexia and vomited occa-
sionally. Since there was no icterus, enlargement of the liver, nor tenderness to
percussion in the right upper quadrant, the patient was continued on tibione. Symptoms
disappeared on May 23, 1950. On June 5, 1950 the bromsulphthalein retention was
141/2%. On June 16 the bromsulphthalein retention was 22% and on June 28 the
bromsulphthalein retention was0%. Tibione was discontinued on June 17. This patient
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had a synovectomy performed on March 22, at which time he received one pint of
bank blood. This case is being considered as a non-icteric viral hepatitis, possibly
homologous serum hepatitis occurring during a course of tibione but unrelated to the
latter. This conclusion is based on the symptomatic improvement that occurred in
spite of the continued administration of tibione and the characteristic histopathology
of the liver in this disease.
Case #11. T. E. L., a 60-year-old white male with far advanced bilateral upper lobe
tuberculosis with cavitation was given tibione for a total of 90 days, 200 mg. a day,
and streptomycin, 1 gram a day. The first liver biopsy done prior to starting tibione
therapy on April 21, 1950 revealed a normal hepatic architecture. The parenchymal
cells were entirely devoid of fat. The second biopsy done on July 25, 1950 revealed
that the liver tissue was essentially unchanged. There was no fatty vacuolization.
Case #12. J. P., a 34-year-old white male with bilateral far advanced apical
tuberculosis, received a total of 120 days of tibione therapy, 200 mg. a day, strepto-
mycin, 1 gram a day, and para-amino-salicylic acid, 13 grams a day. The first liver
biopsy done on 3/28/50 showed a tubercle located within a portal triad. A minimal
trace of fatty vacuolization was present in the parenchymal cells. The second biopsy
was done on April 3, 1950. There were no granulomata. The parenchymal cells were
entirely devoid of fat. The third biopsy done on 7/25/50 showed a normal hepatic
architecture.
Comment. One case treated with combined tibione and streptomycin
(Case #10) developed hepatitis, which was probably homologous serum
jaundice since it subsided during continued treatment. In the two other
cases treated with combined tibione and streptomycin, no evidence of
morphologic change was seen in the liver parenchyma. In the one case
treated with tibione, streptomycin, and para-amino-salicylic acid, there was
similarly no morphologic change in the liver.
Chloromycetin. The following case was treated with Chloromycetin.
Case X13. A. S., a 28-year-old white male, was admitted to the hospital on July 11,
1950 because of an acute osteomyelitis of the right tibia. Incision and drainage of the
osteomyelitic abscess were carried out on 7/12/50 and culture of the pus obtained
revealed a pure growth of Aerobacter aerogenes. Chloromycetin (chloramphenicol),
2.0 grams daily, was started on 7/14/50. After the patient had received a total of 19.5
grams of Chloromycetin, a liver biopsy was performed on 7/24/50 and revealed normal
hepatic tissue. No fatty metamorphosis was present.
Summary
1. Three of four cases treated with aureomycin showed fine fatty
metamorphosis of the liver at the end of thirteen to twenty days of treat-
ment. Forty-four-day post-therapy biopsy in one of these revealed loss
of fat.
2. One case treated with terramycin showed no fatty metamorphosis of
the liver at the end of six days of therapy. Klatskin' has observed fatty
metamorphosis in two patients following a larger quantity administered
over a longer period.
3. Seven cases treated with tibione and various combinations of tibione,
streptomycin, and para-amino-salicylic acid showed no such change, nor
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did one case treated with Chloromycetin. Despite the severe debilitating
febrile courses associated with anorexia and marked weight loss in the
patients with tuberculosis, no fatty metamorphosis of the liver similar to
that following aureomycin therapy was seen.
4. The findings suggest that aureomycin may induce a reversible fatty
metamorphosis of the liver.
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